Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 ...
Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for a nuanced ...
Columnist Jolie Lizana says that an IV pump saved her life, but she's also grateful to have transitioned off it to oral ...
A new clinical classification system is presented to define the severity of an acute PE and assist in developing adult treatment strategies.
Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...
Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.
The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.
Use of race-based reference equations in pulmonary function testing has led to thresholds for what qualifies as impairment in populations.
Medically reviewed by Valerie Cacho, MD Obstructive sleep apnea (OSA) usually does not qualify as a disability on its own.However, severe OSA may be considered a disability if it causes health ...
Studies have demonstrated a critical role of the cytokines thymic stromal lymphopoietin (TSLP), IL-33, and IL-25, produced by epithelial and other cells at mucosal surfaces in response to a wide range ...